Skip to navigation Skip to content

Ocrevus

Share

About this Medication
  • Brand Name: Ocrevus®
  • Chemical Name: ocrelizumab
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This medication is taken by intravenous (IV) infusion.
 

Description

Ocrevus® is a humanized monoclonal antibody that targets CD20 positive B lymphocytes ( a type of white blood cell), which contribute to nerve damage in MS. 

Ocrevus is approved by the FDA for the treatment relapsing forms of multiple sclerosis, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).

Click to read the Prescribing Information for healthcare professionals.
Click to read the Medication Guide for patients.

Support

Genentech
1-844-627-3887

Financial Assistance Program

Genentech® Access Solutions
1-844-627-3887
www.Genentech-Access.com

What You Need to Know About Ocrevus™

This video was created in Summer 2017 and features Derrick Robertson, MD, Janice Maldonado, MD and Kathleen Costello, MSCN. Information is accurate as of then. Please visit www.ocrevus.com for the most updated information.

Share